Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The Manna Transdermal Patch is a cannabis-based delivery system developed by Manna Molecular Science for the management of pain and inflammatory conditions. Utilizing a proprietary transdermal formulation, the patch delivers cannabinoids, specifically tetrahydrocannabinol (THC) and cannabidiol (CBD), directly into the bloodstream through the skin. The product is designed to provide localized and systemic relief for conditions such as back and neck pain. It incorporates additional ingredients like menthol and camphor to enhance its therapeutic effect and is available in various THC:CBD ratios to suit different patient needs. The patch is distributed through cannabis dispensaries in states where medical or recreational cannabis is legal.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Manna Transdermal Patch.